Cholesterol Ratio Calculator

Why Cholesterol Ratios Matter

A standard lipid panel returns four numbers — Total Cholesterol, HDL, LDL, and Triglycerides — and most people focus on LDL alone. That is understandable: LDL cholesterol is the primary target of statin therapy in the ACC/AHA 2018 cholesterol guideline and the ESC/EAS 2019 dyslipidaemia guidelines. But ratios often tell a fuller story about cardiovascular risk than any single number, because they capture the balance between atherogenic lipoproteins (LDL, VLDL, remnants) and protective HDL, and between triglyceride-rich particles and HDL.

Someone with an LDL of 130 mg/dL and an HDL of 70 mg/dL is in a very different situation from someone with the same LDL but an HDL of 30 mg/dL. The second person has a TC/HDL ratio roughly twice as high, reflecting a very different atherogenic burden even though their LDL prints the same on the report.

The Three Core Ratios

Cutoffs reflect commonly used consensus thresholds and published work (Castelli, 1988; Salazar MR et al., Am J Cardiol 2013). They are communication tools, not replacement diagnoses for guideline-based risk scoring.

The Total Cholesterol to HDL Ratio

The TC/HDL ratio was popularised by the Framingham Heart Study investigators, notably William Castelli, as a simple integrator of two of the strongest lipid predictors: total cholesterol burden and the presence of protective HDL. A ratio below 3.5 is typically described as optimal, 3.5–5.0 as average, and values above 5 as associated with materially higher cardiovascular risk in epidemiological work. Very high values above 9 indicate a strongly pro-atherogenic profile and usually warrant clinical attention.

The LDL to HDL Ratio

LDL/HDL isolates the two particles most directly implicated in plaque biology — LDL particles driving deposition into the arterial wall and HDL particles involved in reverse cholesterol transport. Values below 2.5 are usually seen as optimal, 2.5–3.5 as acceptable, and values above 3.5 as progressively concerning. For a person whose total cholesterol is elevated mostly because of high HDL, the LDL/HDL ratio helps separate protective from atherogenic contributions.

The Triglycerides to HDL Ratio

The TG/HDL ratio is the most metabolically interesting of the three because it is a simple surrogate for insulin resistance and the presence of small dense LDL particles. Salazar MR and colleagues showed in a 2013 American Journal of Cardiology paper that a TG/HDL cutoff of approximately 3.0 in mg/dL (about 1.33 in mmol/L) discriminated insulin resistance well in middle-aged adults. Subsequent studies have replicated this, though cutoffs vary across populations and by sex, ethnicity, and age. In clinical practice, a high TG/HDL is a strong signal that metabolic dysfunction may be present — a cue to assess fasting glucose, HbA1c, and insulin.

The Atherogenic Index of Plasma (AIP)

The Atherogenic Index of Plasma, introduced by Dobiasova and Frohlich in 2001, is defined as log10(TG / HDL), with both values in mmol/L. It was designed to correlate with the fraction of small dense LDL particles, which are more atherogenic than larger buoyant LDL. Typical published interpretive bands are: below 0.11 low risk, 0.11 to 0.21 intermediate risk, above 0.21 higher risk. AIP is an academic marker rather than a clinical target, but it is commonly reported in lipidology research and is included here for completeness.

Non-HDL Cholesterol: Often More Useful Than LDL Alone

Non-HDL cholesterol is calculated as Total Cholesterol minus HDL. It captures all atherogenic lipoproteins — LDL, IDL, VLDL and its remnants, and Lp(a) — in one number. The NCEP ATP III framework and subsequent guidelines (AHA/ACC, ESC/EAS) use non-HDL as a secondary lipid target, with a commonly cited goal of below 130 mg/dL (3.4 mmol/L) for average-risk adults, and lower goals for higher-risk groups. Non-HDL becomes particularly useful when triglycerides are elevated, because the Friedewald LDL estimate becomes less reliable above about 400 mg/dL (4.5 mmol/L).

Beyond Ratios: What Else Matters

Ratios are a helpful lens, but they do not replace comprehensive risk assessment. For a fuller picture, clinicians typically consider:

• Apolipoprotein B (apoB) — counts atherogenic particles directly, one per LDL/IDL/VLDL/Lp(a), and is increasingly regarded as superior to LDL-C for many patients.
• Lipoprotein(a), or Lp(a) — a genetically determined LDL-like particle that is an independent cardiovascular risk factor.
• High-sensitivity CRP (hs-CRP) — a marker of low-grade inflammation that modifies cardiovascular risk.
• HbA1c and fasting glucose — metabolic status strongly modulates how cholesterol behaves.
• Blood pressure — the single largest modifiable contributor to cardiovascular events globally.

Ratios are best used as a communication tool and an early-warning signal — not as a standalone risk score. For formal risk prediction, clinicians use validated calculators such as the ACC/AHA Pooled Cohort Equations or SCORE2 from the European Society of Cardiology, which combine lipids with age, sex, blood pressure, smoking, and diabetes.